TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 36,797 | 22,897 | 21,748 |
Financial expenses | 6 | 2 | 31 |
Earnings before taxes | 250 | -12,737 | -12,214 |
EBITDA | 3,286 | -12,307 | -9,857 |
Total assets | 40,241 | 41,314 | 37,850 |
Current assets | 33,084 | 35,185 | 24,223 |
Current liabilities | 9,772 | 6,096 | 8,497 |
Equity capital | 30,377 | 35,127 | 25,329 |
- share capital | 25,224 | 25,224 | 25,224 |
Employees (average) | 20 | 16 | 18 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 75.5% | 85.0% | 66.9% |
Turnover per employee | 1,840 | 1,431 | 1,208 |
Profit as a percentage of turnover | 0.7% | -55.6% | -56.2% |
Return on assets (ROA) | 0.6% | -30.8% | -32.2% |
Current ratio | 338.6% | 577.2% | 285.1% |
Return on equity (ROE) | 0.8% | -36.3% | -48.2% |
Change turnover | 13,900 | 1,149 | -6,600 |
Change turnover % | 61% | -23% | |
Chg. No. of employees | 4 | -2 | 0 |
Chg. No. of employees % | 25% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.